CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-25 | HEALY JAMES Director | Grant or award | +142 | 46,260 | ||
| 2025-01-31 | HEALY JAMES Director | Grant or award | +114 | 46,118 | ||
| 2024-10-25 | HEALY JAMES Director | Grant or award | +153 | 46,004 | ||
| 2024-07-26 | HEALY JAMES Director | Grant or award | +177 | 45,851 | ||
| 2024-06-28 | HEALY JAMES Director | Grant or award | +2,964 | 45,674 | ||
| 2024-04-26 | HEALY JAMES Director | Grant or award | +210 | 42,710 | ||
| 2024-01-26 | HEALY JAMES Director | Grant or award | +264 | $63.79 | $17K | 42,500 |
| 2023-12-13 | HEALY JAMES Director | Sale | −644,000 | $58.75 | $37.8M | 0 |
| 2023-10-27 | HEALY JAMES Director | Grant or award | +396 | $42.60 | $17K | 42,236 |
Page 1 of 1 · 9 trades